Additive effect on -ve inotropic effects w/ Ca channel blockers eg, verapamil & diltiazem, particularly in patients w/ impaired ventricular function &/or SA or AV conduction abnormalities. Increased risk of hypotension & cardiac failure w/ dihydropyridines (eg, nifedipine) in patients w/ latent cardiac insufficiency. Increased AV conduction time w/ digitalis glycosides. β-blockers may exacerbate the rebound HTN which can follow the withdrawal of clonidine. Potentiated effect on atrial conduction time & induction of -ve inotropic effect w/ class I anti-arrhythmics (eg, disopyramide) & amiodarone. Sympathomimetics (eg, epinephrine) may counteract the effect of β-blockers. Intensified blood sugar lowering effect of insulin & oral antidiabetic drugs. Decreased hypotensive effects w/ prostaglandin synthetase-inhibiting drugs eg, ibuprofen & indomethacin.